Treatment of diseases, disorders or conditions of the lung using placental cells

Details for Australian Patent Application No. 2009316376 (hide)

Owner Anthrogenesis Corporation

Inventors Hariri, Robert J.; Faleck, Herbert; Zeitlin, Andrew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009316376

PCT Pub. Number WO2010/060031

Priority 61/117,004 21.11.08 US

Filing date 23 November 2009

Wipo publication date 27 May 2010

International Classifications

A01N 63/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates - Microbial fungi

A01N 65/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/060031 Priority application(s): WO2010/060031

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316380-Snake Factor V and methods of use as a procoagulant

2009316372-Laminated articles comprising a sheet of a blend of ethylene copolymers